Lynn A. Tetrault - Net Worth and Insider Trading
Lynn A. Tetrault Net Worth
The estimated net worth of Lynn A. Tetrault is at least $983,681 dollars as of 2024-11-08. Lynn A. Tetrault is the Director of NeoGenomics Inc and owns about 50,062 shares of NeoGenomics Inc (NEO) stock worth over $791,981. Lynn A. Tetrault is also the Director of Rhythm Pharmaceuticals Inc and owns about 3,000 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $191,700. Details can be seen in Lynn A. Tetrault's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lynn A. Tetrault has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lynn A. Tetrault
Lynn A. Tetrault Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lynn A. Tetrault owns 2 companies in total, including NeoGenomics Inc (NEO) , and Rhythm Pharmaceuticals Inc (RYTM) .
Click here to see the complete history of Lynn A. Tetrault’s form 4 insider trades.
Insider Ownership Summary of Lynn A. Tetrault
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NEO | NeoGenomics Inc | 2024-03-04 | director |
| RYTM | Rhythm Pharmaceuticals Inc | 2024-09-10 | director |
Lynn A. Tetrault Latest Holdings Summary
Lynn A. Tetrault currently owns a total of 2 stocks. Among these stocks, Lynn A. Tetrault owns 50,062 shares of NeoGenomics Inc (NEO) as of March 4, 2024, with a value of $791,981 and a weighting of 80.51%. Lynn A. Tetrault also owns 3,000 shares of Rhythm Pharmaceuticals Inc (RYTM) as of September 10, 2024, with a value of $191,700 and a weighting of 19.49%.
Latest Holdings of Lynn A. Tetrault
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NEO | NeoGenomics Inc | 2024-03-04 | 50,062 | 15.82 | 791,981 |
| RYTM | Rhythm Pharmaceuticals Inc | 2024-09-10 | 3,000 | 63.90 | 191,700 |
Holding Weightings of Lynn A. Tetrault
Lynn A. Tetrault Form 4 Trading Tracker
According to the SEC Form 4 filings, Lynn A. Tetrault has made a total of 1 transactions in NeoGenomics Inc (NEO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NeoGenomics Inc is the sale of 6,112 shares on March 4, 2024, which brought Lynn A. Tetrault around $97,609.
According to the SEC Form 4 filings, Lynn A. Tetrault has made a total of 3 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 20,700 shares on September 10, 2024, which brought Lynn A. Tetrault around $1 Million.
Insider Trading History of Lynn A. Tetrault
- 1
Lynn A. Tetrault Trading Performance
GuruFocus tracks the stock performance after each of Lynn A. Tetrault's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lynn A. Tetrault is -13.67%. GuruFocus also compares Lynn A. Tetrault's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lynn A. Tetrault within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lynn A. Tetrault's insider trading performs compared to the benchmark.
Performance of Lynn A. Tetrault
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.65 | | | | | |
| Relative Return to S&P 500(%) | -6.66 | | | | | |
Lynn A. Tetrault Ownership Network
Ownership Network List of Lynn A. Tetrault
Ownership Network Relation of Lynn A. Tetrault
Lynn A. Tetrault Owned Company Details
What does NeoGenomics Inc do?
Who are the key executives at NeoGenomics Inc?
Lynn A. Tetrault is the director of NeoGenomics Inc. Other key executives at NeoGenomics Inc include General Counsel Alicia C Olivo , Chief Accounting Officer Greg D Aunan , and Chief Financial Officer Jeffrey Scott Sherman .
NeoGenomics Inc (NEO) Insider Trades Summary
Over the past 18 months, Lynn A. Tetrault made 1 insider transaction in NeoGenomics Inc (NEO) with a net sale of 6,112. Other recent insider transactions involving NeoGenomics Inc (NEO) include a net sale of 7,345 shares made by Alicia C Olivo ,
In summary, during the past 3 months, insiders sold 1,040 shares of NeoGenomics Inc (NEO) in total and bought 0 shares, with a net sale of 1,040 shares. During the past 18 months, 13,457 shares of NeoGenomics Inc (NEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,457 shares.
NeoGenomics Inc (NEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeoGenomics Inc Insider Transactions
Lynn A. Tetrault Mailing Address
Above is the net worth, insider trading, and ownership report for Lynn A. Tetrault. You might contact Lynn A. Tetrault via mailing address: 12701 Commonwealth Drive, Suite 9, Fort Myers Fl 33913.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
